Renal p38 MAP kinase activity in experimental diabetes

Area of Science:

• Nephrology
• Molecular Biology
• Endocrinology

Background:

• p38 mitogen-activated protein kinase (p38) signaling is implicated in diabetic nephropathy (DN) pathogenesis.
• Renal p38 activity in Type 1 diabetes, especially concerning metabolic control and advanced DN, requires further investigation.

Purpose of the Study:

• To investigate renal p38 pathway activity in a rat model of Type 1 diabetes with varying degrees of metabolic control.
• To assess p38 activity in early and advanced stages of diabetic nephropathy in vivo.
• To explore the mechanisms regulating p38 activation in diabetic kidneys.

Main Methods:

• Streptozotocin-induced diabetes in rats with poor, moderate, and intensive insulin therapy (4 weeks).
• Assessment of p38 activity via in vitro kinase assays and phosphorylated p38 (P-p38) expression.
• Analysis of P-p38 localization in renal cells (macula densa, distal tubule, glomeruli).
• Evaluation of related protein expression (MAPK 3/6, TAB1, MKP-1) and p38 activity in 12-month diabetic rats with established nephropathy.

Main Results:

• p38 activity was elevated in diabetic rats (DM, DS) compared to controls, and reduced by intensive insulin treatment.
• Increased P-p38 was observed in macula densa cells, distal tubules, and glomeruli of diabetic rats.
• p38 activation correlated with increased TAB1 but not active MAPK 3/6; MKP-1 expression was elevated in all diabetic groups.
• Renal p38 activation was present in diabetic rats with established albuminuria and glomerulosclerosis (DM12).

Conclusions:

• Renal cortical p38 activity is upregulated in both early and advanced stages of diabetic nephropathy.
• Improved metabolic control attenuates renal p38 activation in diabetes.
• p38 activation in diabetes involves multiple pathways and is not solely due to MKP-1 downregulation.